Summit Therapeutics Inc. (SMMT)

Import this data to Google Sheets with:

=jivedata("SMMT","financials")

Full statements spill as a table. For one cell: =jivedata("SMMT","Revenue") or =jivedata("SMMT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Summit Therapeutics Inc.

SMMT • CIK 0001599298

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Research and Development Expense (Excluding Acquired in Process Cost)	—	$150,777	$537,674	$537,674
Nonoperating Income (Expense)	$-5,278	$13,369	$14,838	$18,755
General and Administrative Expense	$30,265	$60,527	$556,750	$306,105
InterestExpenseNonoperating	—	$8,686	$0	$0
Operating Expenses	$610,651	$226,311	$1,094,424	$874,844
Net Income (Loss) Attributable to Parent	$-614,928	$-221,315	$-1,079,586	$-856,089
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-615,483	$-221,152	$-1,079,841	$-856,002
Weighted Average Number of Shares Outstanding, Basic	619,646,180	718,541,896	747,702,265	784,169,033
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax	$-172	$60	$-327	$125
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI for Write-down of Securities, Net of Tax	—	$3	$0	$0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax	$419	$0	$0	$0
OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax	—	$100	$72	$-38

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$71,425	$104,862	$225,266	$419,365
Restricted Cash, Current	$0	$325	$316	$317
Short-term Investments	$114,817	$307,487	$488,182	$271,313
Assets	$202,949	$435,560	$751,182	$752,185
Prepaid Expense and Other Assets, Current	—	$10,519	$6,537	$29,583
Assets, Current	$189,712	$423,750	$720,301	$720,578
Property, Plant and Equipment, Net	$204	$254	$1,059	$1,781
Operating Lease, Right-of-Use Asset	$5,859	$7,144	$20,616	$19,410
Goodwill	$1,893	$1,864	$2,001	$1,968
Liabilities	$125,257	$46,812	$92,322	$122,202
Other Assets, Noncurrent	$4,322	$1,850	$7,205	$8,448
Accounts Payable, Current	$2,667	$4,636	$20,292	$22,896
Accrued Liabilities, Current	$8,783	$19,554	$32,100	$65,055
Employee-related Liabilities, Current	$5,429	$11,977	$14,925	$9,443
Operating Lease, Liability, Current	$2,809	$3,765	$3,388	$3,550
Other Liabilities, Current	$717	$1,797	$2,283	$2,622
Liabilities, Current	$20,405	$41,729	$72,988	$103,566
Operating Lease, Liability, Noncurrent	$3,290	$3,453	$17,502	$16,834
Other Liabilities, Noncurrent	$1,562	$1,630	$1,832	$1,802
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$7,017	$7,376	$7,754	$7,931
Additional Paid in Capital	$1,066,381	$1,598,230	$2,947,805	$3,324,000
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-2,448	$-2,285	$-2,540	$-2,665
Retained Earnings (Accumulated Deficit)	$-993,258	$-1,214,573	$-2,294,159	$-2,699,283
Stockholders' Equity Attributable to Parent	$77,692	$388,748	$658,860	$629,983
Preferred Stock, Shares Authorized	20,000,000	20,000,000	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	1,000,000,000	1,000,000,000	1,000,000,000	1,000,000,000
Common Stock, Shares, Issued	701,660,053	737,626,004	775,371,200	793,120,362

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$839	$-18	$102	$-15
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-577,182	$33,762	$120,395	$121,491
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$71,425	$105,187	$225,582	$120,569
Net Income (Loss) Attributable to Parent	$-614,928	$-221,315	$-1,079,586	$-856,089
Net Cash Provided by (Used in) Operating Activities	$-76,760	$-142,106	$-322,930	$-458,433
Proceeds from Sale, Maturity and Collection of Short-term Investments	$208,165	$489,837	$311,340	$626,088
Payments to Acquire Short-term Investments	$321,022	$680,032	$484,993	$887,269
Payments to Acquire Property, Plant, and Equipment	$128	$139	$657	$1,389
Proceeds from Sale of Property, Plant, and Equipment	$226	$0	$0	$0
Net Cash Provided by (Used in) Investing Activities	$-587,774	$-205,341	$-174,310	$-262,570
Proceeds from Issuance of Private Placement	$5,000	$434,860	$500,037	$500,037
Proceeds from Issuance of Common Stock	$104,686	—	—	—
Proceeds from Warrant Exercises	$1,203	$598	$7,315	$0
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$929	$2,736	$5,653	$10,531
Payments of Stock Issuance Costs	$619	$0	$0	$0
Repayments of Related Party Debt	$24,686	$100,000	$0	$0
Net Cash Provided by (Used in) Financing Activities	$86,513	$381,227	$617,533	$842,509
Interest Paid, Excluding Capitalized Interest, Operating Activities	$10,650	$8,806	$0	$0
Income Taxes Paid, Net	$52	$0	$0	$0
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$4,245	$4,216	$17,056	$17,765
Capital Expenditures Incurred but Not yet Paid	—	—	$291	$219
Accretion (Amortization) of Discounts and Premiums, Investments	$1,924	$2,576	$7,006	$10,203
Foreign Currency Transaction Gain (Loss), Unrealized	$812	$-229	$320	$-363
Tangible Asset Impairment Charges	$474	$0	$0	$0
Depreciation	$198	$89	$146	$174
Share-based Payment Arrangement, Noncash Expense	$14,108	$50,981	$732,420	$384,037
Gain (Loss) on Disposition of Assets	$109	$0	$0	$0
Increase (Decrease) in Prepaid Expense and Other Assets	—	$7,905	$-4,866	$18,099
Increase (Decrease) in Other Operating Assets	$3,421	$-2,470	$4,875	$4,875
Increase (Decrease) in Accounts Payable	$2,263	$2,015	$15,303	$-89
Increase (Decrease) in Accrued Liabilities	$-2,377	$11,879	$12,930	$39,433
Increase (Decrease) in Employee Related Liabilities	$-235	$6,557	$2,909	$2,834
Increase (Decrease) in Other Noncurrent Liabilities	—	$95	$80	$-2

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("SMMT","financials")

Full statements spill as a table. For one cell: =jivedata("SMMT","Revenue") or =jivedata("SMMT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.